{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:04:48Z","timestamp":1772546688236,"version":"3.50.1"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015976","name":"State Key Laboratory of Pathogen and Biosecurity","doi-asserted-by":"publisher","award":["SKLPBS2462"],"award-info":[{"award-number":["SKLPBS2462"]}],"id":[{"id":"10.13039\/501100015976","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Influenza A virus (IAV) remains one of the major global health threats, and a rapid emerging resistance to direct acting antivirals underscores the need for host directed therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Here, we integrated prior knowledge inference with a multilevel phenotypic screening and computational multi-omics analysis to identify natural candidate chemical compounds from Traditional Chinese Medicine (TCM)\u2013derived libraries. Twenty compounds enriched for links to antiviral signaling were tested via a GFP-IAV reporter assay, followed by experimental validation using replication kinetics of wild type IAV in MDCK and A549 cells, cytotoxicity measurements, and a viral polymerase minigenome assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Four structurally distinct compounds, Aloe emodin, Cryptotanshinone, Emodin, and Andrographolide, consistently inhibited IAV replication with low cytotoxicity. The polymerase assay results indicated no substantial direct inhibition of viral polymerase, except for modest effects of Aloe emodin at high concentration. Transcriptomic and proteomic profiling of compound-treated and virus-infected A549 cells showed that all four compounds reprogrammed host antiviral and inflammatory networks, including innate immune and stress response pathways, and virus-host interaction modules.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These findings nominate the four natural chemical compounds as promising antiviral scaffolds against IAV.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1771638","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T09:37:58Z","timestamp":1772530678000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating prior knowledge inference with computational multi-omics analysis to reveal host antiviral networks of natural compounds against influenza A virus"],"prefix":"10.3389","volume":"16","author":[{"given":"Xu","family":"Chen","sequence":"first","affiliation":[{"name":"College of Traditional Chinese Medicine, Inner Mongolia Medical University","place":["Hohhot, Inner Mongolia, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking Union Medical College Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Inner Mongolia Medical University","place":["Hohhot, Inner Mongolia, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Dang","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Inner Mongolia Medical University","place":["Hohhot, Inner Mongolia, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Qi","family":"Jiao","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Inner Mongolia Medical University","place":["Hohhot, Inner Mongolia, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ri","family":"Hai","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Inner Mongolia Medical University","place":["Hohhot, Inner Mongolia, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Lu","family":"Ma","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Inner Mongolia Medical University","place":["Hohhot, Inner Mongolia, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Mei","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Inner Mongolia Medical University","place":["Hohhot, Inner Mongolia, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-He","family":"Li","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences, Inner Mongolia Medical University","place":["Hohhot, Inner Mongolia, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Ping","family":"Shi","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Inner Mongolia Medical University","place":["Hohhot, Inner Mongolia, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.antiviral.2019.04.006","article-title":"Advances in respiratory virus therapeutics - a meeting report from the 6th isirv Antiviral Group conference","volume":"167","author":"Beigel","year":"2019","journal-title":"Antiv. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s11095-024-03742-x","article-title":"Machine learning prediction of on\/off target-driven clinical adverse events","volume":"41","author":"Cao","year":"2024","journal-title":"Pharm. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11262-022-01904-w","article-title":"An overview of influenza a virus genes, protein functions, and replication cycle highlighting important updates","volume":"58","author":"Chauhan","year":"2022","journal-title":"Virus Genes."},{"key":"B4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/s12967-020-02476-9","article-title":"A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals","volume":"18","author":"Chitalia","year":"2020","journal-title":"J. Transl. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.3390\/molecules22101754","article-title":"Emodin Inhibition of Influenza a Virus Replication and Influenza Viral Pneumonia via the Nrf2, TLR4, p38\/JNK and NF-kappaB Pathways","volume":"22","author":"Dai","year":"2017","journal-title":"Molecules."},{"key":"B6","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.1080\/07391102.2023.2233026","article-title":"Virtual screening and molecular growth guide the design of inhibitors for the influenza virus drug-resistant mutant M2-V27a\/S31N","volume":"42","author":"Deng","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S1875-5364(23)60505-9","article-title":"Anti-hepatitis B virus activities of natural products and their antiviral mechanisms","volume":"21","author":"Deng","year":"2023","journal-title":"Chin. J. Nat. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s11427-017-9152-1","article-title":"Phylogenetic and genetic characterization of a 2017 clinical isolate of H7N9 virus in Guangzhou, China during the fifth epidemic wave","volume":"60","author":"Deng","year":"2017","journal-title":"Sci. CN. Life Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(15)01282-9","article-title":"Oseltamivir for influenza","volume":"387","author":"Doshi","year":"2016","journal-title":"Lancet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/ph15010028","article-title":"Baloxavir marboxil: an original new drug against influenza","volume":"15","author":"Dufrasne","year":"2021","journal-title":"Pharmaceuticals."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2024.343551","article-title":"Emerging opportunities for intact and native protein analysis using chemical proteomics","volume":"1338","author":"Edwards","year":"2025","journal-title":"Anal. Chim. Acta"},{"key":"B12","doi-asserted-by":"publisher","first-page":"eabm6668","DOI":"10.1126\/sciadv.abm6668","article-title":"Apolipoprotein E mediates cell resistance to influenza virus infection","volume":"8","author":"Gao","year":"2022","journal-title":"Sci. Adv."},{"key":"B13","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nature11005","article-title":"Systematic identification of genomic markers of drug sensitivity in cancer cells","volume":"483","author":"Garnett","year":"2012","journal-title":"Nature."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jip.2020.107473","article-title":"C-type lectin 5, a novel pattern recognition receptor for the JAK\/STAT signaling pathway in Bombyx mori","volume":"179","author":"Geng","year":"2021","journal-title":"J. Invertebr. Pathol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.toxlet.2023.07.011","article-title":"Off target toxicities and links with physicochemical properties of medicinal products, including antibiotics, oligonucleotides, lipid nanoparticles (with cationic and\/or anionic charges). Data review suggests an emerging pattern","volume":"384","author":"Gould","year":"2023","journal-title":"Toxicol. Lett."},{"key":"B16","doi-asserted-by":"publisher","first-page":"6030","DOI":"10.1038\/s41467-023-41442-z","article-title":"Proteomic and genetic analyses of influenza a viruses identify pan-viral host targets","volume":"14","author":"Haas","year":"2023","journal-title":"Nat. Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s40001-023-01006-9","article-title":"The efficacy of traditional Chinese medicine in the treatment of the COVID-19 pandemic in Henan Province: a retrospective study","volume":"28","author":"Han","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.coviro.2011.09.002","article-title":"Antivirals and resistance: influenza virus","volume":"1","author":"Ison","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jinf.2010.10.003","article-title":"Oseltamivir, zanamivir and amantadine in the prevention of influenza: a systematic review","volume":"62","author":"Jackson","year":"2011","journal-title":"J. Infect."},{"key":"B20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd.2017.162","article-title":"Host-directed therapies for bacterial and viral infections","volume":"17","author":"Kaufmann","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116172","article-title":"Tackling Influenza a virus by M2 ion channel blockers: Latest progress and limitations","volume":"267","author":"Kumar","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/s41564-025-01940-w","article-title":"ARF4-mediated intracellular transport as a broad-spectrum antiviral target","volume":"10","author":"Li","year":"2025","journal-title":"Nat. Microbiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/s0149-2918(08)80048-3","article-title":"Maraviroc: a CCR5-receptor antagonist for the treatment of HIV-1 infection","volume":"30","author":"Lieberman-Blum","year":"2008","journal-title":"Clin. Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1038\/s41467-025-56496-4","article-title":"Structurally convergent antibodies derived from different vaccine strategies target the influenza virus HA anchor epitope with a subset of V(H)3 and V(K)3 genes","volume":"16","author":"Lin","year":"2025","journal-title":"Nat. Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"13344","DOI":"10.1128\/JVI.01777-14","article-title":"Occurrence and reassortment of avian influenza a (H7N9) viruses derived from coinfected birds in China","volume":"88","author":"Liu","year":"2014","journal-title":"J. Virol."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-014-0271-x","article-title":"Development of reverse-transcription loop-mediated isothermal amplification assay for rapid detection of novel avian influenza a (H7N9) virus","volume":"14","author":"Liu","year":"2014","journal-title":"BMC Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0185723","DOI":"10.1128\/jvi.01857-23","article-title":"Systematic review and meta-analysis of genome-wide pooled CRISPR screens to identify host factors involved in influenza a virus infection","volume":"98","author":"Maes","year":"2024","journal-title":"J. Virol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.immuni.2025.02.006","article-title":"Antigenic drift expands influenza viral escape pathways from recalled humoral immunity","volume":"58","author":"Maurer","year":"2025","journal-title":"Immunity."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/immhor\/vlaf024","article-title":"Influenza a virus disruption of dendritic cell-natural killer cell crosstalk impacts activation of na\u00efve helper and cytotoxic T cell subsets","volume":"9","author":"Morson","year":"2025","journal-title":"Immunohorizons."},{"key":"B30","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3390\/molecules26040880","article-title":"Influenza viruses: harnessing the crucial role of the M2 ion-channel and neuraminidase toward inhibitor design","volume":"26","author":"Mtambo","year":"2021","journal-title":"Molecules."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2023.101360","article-title":"Hepatitis-B virus: replication cycle, targets, and antiviral approaches","volume":"63","author":"Nasser","year":"2023","journal-title":"Curr. Opin. Virol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nature08157","article-title":"Emergence and pandemic potential of swine-origin H1N1 influenza virus","volume":"459","author":"Neumann","year":"2009","journal-title":"Nature."},{"key":"B33","doi-asserted-by":"publisher","first-page":"eadq0900","DOI":"10.1126\/science.adq0900","article-title":"Emergence and interstate spread of highly pathogenic avian influenza a(H5N1) in dairy cattle in the United States","volume":"388","author":"Nguyen","year":"2025","journal-title":"Sci. (New York N.Y.)."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1431979","article-title":"Screening for anti-influenza virus compounds from traditional Mongolian medicine by GFP-based reporter virus","volume":"14","author":"Nie","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/ve\/vez046","article-title":"Evolution and rapid spread of a reassortant a(H3N2) virus that predominated the 2017\u20132018 influenza season","volume":"5","author":"Potter","year":"2019","journal-title":"Virus Evol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s40249-024-01263-8","article-title":"Recent advancements in traditional Chinese medicine for COVID-19 with comorbidities across various systems: a scoping review","volume":"13","author":"Shang","year":"2024","journal-title":"Infect. Dis. Povert."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107512","article-title":"Favipiravir, an anti-influenza drug against life-threatening RNA virus infections","volume":"209","author":"Shiraki","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1080\/20477724.2025.2536906","article-title":"Influenza strains in focus: global approaches to the diagnosis, treatment, and control of H1N1, H3N2, H7N9, and H9N2","volume":"119","author":"Singh","year":"2025","journal-title":"Pathog. Glob. Health"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e38243","article-title":"A mechanistic review of the pharmacological aspects of Kaempferide as a natural compound","volume":"10","author":"Song","year":"2024","journal-title":"Heliyon."},{"key":"B40","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.phymed.2011.01.026","article-title":"Silymarin efficacy against influenza a virus replication","volume":"18","author":"Song","year":"2011","journal-title":"Phytomedicine."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e93366","DOI":"10.1371\/journal.pone.0093366","article-title":"U4 at the 3\u2019 UTR of PB1 segment of H5N1 influenza virus promotes RNA polymerase activity and contributes to viral pathogenicity","volume":"9","author":"Sun","year":"2014","journal-title":"PloS One"},{"key":"B42","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1128\/JVI.02510-13","article-title":"Comparative virus replication and host innate responses in human cells infected with three prevalent clades (2.3.4, 2.3.2, and 7) of highly pathogenic avian influenza H5N1 viruses","volume":"88","author":"Sun","year":"2014","journal-title":"J. Virol."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.r2480","article-title":"Man in first ever human case of H5N5 avian flu dies","volume":"391","author":"Taylor","year":"2025","journal-title":"BMJ (Clin Res. Ed.)."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1436557","article-title":"Future applications of host direct therapies for infectious disease treatment","volume":"15","author":"Thom","year":"2024","journal-title":"Front. Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"12834","DOI":"10.1021\/ja204969m","article-title":"Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza a virus M2","volume":"133","author":"Wang","year":"2011","journal-title":"J. Am. Chem. Soc"},{"key":"B46","doi-asserted-by":"publisher","first-page":"nwaf396","DOI":"10.1093\/nsr\/nwaf396","article-title":"Deep learning predicts potential reassortments of avian H5N1 with human influenza viruses","volume":"12","author":"Wei","year":"2025","journal-title":"Natl. Sci. Rev."},{"key":"B47","volume-title":"Influenza update N\u00b0 551. [Reprinted]","year":"2025"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.3762\/bjoc.20.199","article-title":"Improved deconvolution of natural products\u2019 protein targets using diagnostic ions from chemical proteomics linkers","volume":"20","author":"Wiest","year":"2024","journal-title":"Beilstein. J. Org. Chem."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac381","article-title":"Applying lessons learned from COVID-19 therapeutic trials to improve future ALI\/ARDS trials","volume":"9","author":"Wu","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.769011","article-title":"A practical strategy for exploring the pharmacological mechanism of luteolin against COVID-19\/asthma comorbidity: findings of system pharmacology and bioinformatics analysis","volume":"12","author":"Xie","year":"2021","journal-title":"Front. Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"6288","DOI":"10.1038\/s41467-022-33909-2","article-title":"The influenza virus PB2 protein evades antiviral innate immunity by inhibiting JAK1\/STAT signalling","volume":"13","author":"Yang","year":"2022","journal-title":"Nat. Commun."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14740338.2025.2524400","article-title":"Neural dysfunction, inflammatory disorder, and metabolic interference feature in amantadine-related adverse drug events: a perspective from FAERS and network toxicology","author":"Yang","year":"2025","journal-title":"Expert Opin. Drug Saf."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.3390\/v15081646","article-title":"Host DNA demethylation induced by DNMT1 inhibition up-regulates antiviral OASL protein during influenza a virus infection","volume":"15","author":"Zhao","year":"2023","journal-title":"Viruses."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1771638\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T09:37:59Z","timestamp":1772530679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1771638\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":53,"alternative-id":["10.3389\/fcimb.2026.1771638"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1771638","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"article-number":"1771638"}}